Researchers evaluated the association between Assessment of Spondyloarthritis International Society Health Index (ASAS-HI) and disease activity and burden in patients with spondyloarthritis.
Researchers assessed data on intestinal permeability in patients with spondyloarthritis and rheumatoid arthritis and the effects of nonsteroidal anti-inflammatory drugs on intestinal permeability.
Using the CORRONA (now CorEvitas) PsA/SpA Registry, study authors compared the characteristics of patients with axial psoriatic arthritis and axial spondyloarthritis.
Researchers assessed the efficacy and safety of tofacitinib in adult patients with active ankylosing spondylitis.
The primary objective of the study was to compare the clinical characteristics of patients with spondyloarthritis with and without root joint disease.
Researchers assessed the efficacy and safety of IL-17 inhibitor brodalumab in patients with axial spondyloarthritis.
Researchers described driving difficulties among patients with axial spondyloarthritis and characterized clinical and sociodemographic features and impact on work.
Researchers evaluated gastrointestinal-related adverse events in patients with psoriatic arthritis and ankylosing spondylitis who were initiating secukinumab.
Researchers collected data on patient-reported outcome measures in spondyloarthritis from patients with psoriatic arthritis and ankylosing spondylitis.
A deep dive into the classification criteria, diagnosis, and implications for therapy in axial spondyloarthritis.